Subject: New PROTECTION PANTY awarded funding for initial phase of FDA trials.
A private corporation located in Sebastopol, California, announced that they will receive funding from N I C H D (National Institute of Child Health and Human Development Grant Number: 1 R43 HD35407-01A1) for the first phase of testing a new style prophylactic/contraceptive, which is worn by the woman during sex.
for Jane ( Everywoman ) Doe, will be tested at California Family Health
Council located in Los Angeles, under the supervision of Ron Frezieres,
Principle Investigator for .
The first testing will take approximately two months, and is expected
to begin after July 1 this year.
Many men might enjoy having an option for prevention of pregnancy or disease. Currently, men have no choice for reproductive health and safety except male condoms, which some men find uncomfortable or difficult to use. Women, although they have many means to prevent pregnancy, have no protection that can provide a full barrier against disease. And for some women, chemical birth control becomes more risky as they grow older. A product such as is often called a "two for one" meaning that because it is a barrier to both disease and pregnancy, two health benefits are received.
Although the first to reach the market will be completely disposable, future models will feature interchangeable parts. When has been shown in public, many men express interest in the new sexy panty, while most women are clearly delighted at the prospect of having such a convenient, appealing and easy to operate means for optimizing reproductive safety. Currently women purchase more than 60% of male condoms in the USA.
The most feared sexually transmitted disease is AIDS, but there are many other diseases which could be effectively prevented by a barrier method such as , especially herpes, which is often located outside the area of a condoms use. Herpes can be controlled by medication, but has no cure, and can cause blindness to babies in the birth canal. Genital warts, another disease frequently outside the condom barrier area, is now known to be a precursor to cancers of the reproductive system. Some diseases, like chlamydia, gonorrhea and syphilis, can make conception rates low, or cause permanent infertility.
Clinics, health counselors, doctors
and nurses who would like to be placed on a mailing list can send letters
to the address below. No samples are available at this time, due
to federal regulation.
Ron Frezierez (Principal Investigator)
HHH Development Co., Inc. (the
guardian corporation for )